Genetic differences between BRCA-associated and sporadic ovarian cancer DNA

被引：0
|
作者：
Walsh, C. S.
Ogawa, S.
Scoles, D.
Pavelka, J.
Miller, C.
Kawamata, N.
Narod, S.
Koeffler, H. P.
Karlan, B. Y.
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Univ Tokyo, Tokyo, Japan
[3] Univ Toronto, Toronto, ON, Canada
来源：
GYNECOLOGIC ONCOLOGY | 2007年 / 107卷 / 02期
关键词：
D O I：
10.1016/j.ygyno.2007.08.027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：367 / 368
页数：2
相关论文
共 50 条
  • [31] PARP-Inhibitors in BRCA-Associated Pancreatic Cancer
    Bhalla, Anshul
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2014, 15 (04): : 340 - 343
  • [32] Diet quality predicts BRCA-associated breast cancer risk
    Nkondjock, Andre
    Ghadirian, Parviz
    JOURNAL OF NUTRITION, 2007, 137 (01): : 282S - 282S
  • [33] Survival benefit for BRCA-associated epithelial ovarian cancer (OC) is not explained by primary platinum sensitivity alone
    Konner, J. A.
    Gallagher, D. J.
    Bell-McGuinn, K. M.
    Hansen, J.
    Kosarin, K.
    Aghajanian, C. A.
    Offit, K.
    Barakat, R. R.
    Spriggs, D. R.
    Kauff, N. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] Rethinking breast cancer surveillance in women with BRCA-associated ovarian cancer in the post-solo trial era.
    John, Catherine S.
    Amersi, Farin F.
    Fong, Abigail
    Gillen, Jessica
    Moore, Kathleen N.
    Walsh, Christine S.
    Li, Andrew John
    Rimel, Bj
    Cass, Ilana
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer
    McCabe, N.
    Cerone, M. A.
    Ohishi, T.
    Seimiya, H.
    Lord, C. J.
    Ashworth, A.
    ONCOGENE, 2009, 28 (11) : 1465 - 1470
  • [36] Clinicopathological characteristics of BRCA-associated breast cancer in Asian patients
    Kim, Eun-Kyu
    Park, So Yeon
    Kim, Sung-Won
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2020, 54 (04) : 265 - 275
  • [37] Breast MRI texture analysis for prediction of BRCA-associated genetic risk
    Vasileiou, Georgia
    Costa, Maria J.
    Long, Christopher
    Wetzler, Iris R.
    Hoyer, Juliane
    Kraus, Cornelia
    Popp, Bernt
    Emons, Julius
    Wunderle, Marius
    Wenkel, Evelyn
    Uder, Michael
    Beckmann, Matthias W.
    Jud, Sebastian M.
    Fasching, Peter A.
    Cavallaro, Alexander
    Reis, Andre
    Hammon, Matthias
    BMC MEDICAL IMAGING, 2020, 20 (01)
  • [38] BRCA-associated cancer risk:: Molecular biology and clinical practice
    van Golen, K
    Milliron, K
    Davies, S
    Merajver, SD
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 134 (01): : 11 - 18
  • [39] CHARACTERISTICS OF BRCA-ASSOCIATED BREAST CANCER IN THE POPULATION OF THE RUSSIAN FEDERATION
    Novikova, E., I
    Kudinova, E. A.
    Bozhenko, V. K.
    Solodkiy, V. A.
    BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY, 2021, (01): : 26 - 32
  • [40] BRCA-associated breast cancer:: absence of a characteristic immunophenotype.
    Haas, B
    Robson, M
    Rajan, P
    Rosen, PP
    Borgen, P
    Brown, K
    Hampel, H
    Schulz, C
    Gilewski, T
    Norton, L
    Offit, K
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A67 - A67
12345